BIG
SAGE

Brooklyn Investment Group’s Sage Therapeutics SAGE Stock Holding History

Brooklyn Investment Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-788
Closed -$7.19K – 2278
2025
Q2 		$7.19K Buy
788
+121
+18% +$890 ﹤0.01% 2331
2025
Q1 		$5.3K Sell
667
-233
-26% -$1.71K ﹤0.01% 1800
2024
Q4 		$4.89K Buy
+900
New +$5.5K ﹤0.01% 1219

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brooklyn Investment Group's SAGE Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 788 shares — an estimated $7.19K sold.

Brooklyn Investment Group first reported a position in SAGE in Q4 2024 and held it in 3 quarters. The position peaked at $7.19K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 788 Sage Therapeutics shares in Q3 2025, an estimated $7.19K.
  • Brooklyn Investment Group first reported a position in Sage Therapeutics in Q4 2024 and held it in 3 quarters.
  • Brooklyn Investment Group's Sage Therapeutics position peaked at $7.19K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.